Navigation Links
Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
Date:5/28/2008

PHILADELPHIA, May 28 /PRNewswire/ -- Premier Research Group plc (AIM: PRG), the international pharmaceutical services group, announces the appointment of Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety. In this position, Dr. Faragasso will lead the global Medical Management and Safety team ensuring the delivery of quality medical and safety services

Dr. Faragasso brings to Premier Research a wealth of experience in global safety monitoring, post marketing surveillance, and risk management planning. He started his pharmaceutical career in Ortho Pharmaceutical Corp. in 1985 after completing his medical degree and fellowship training in infectious diseases. Since then he held positions with increasing responsibilities in pharmaceutical companies and CROs including: Rhone Poulenc Rorer Central Research; Synergen, Inc.; Centocor, Inc.; OmniCare (formerly IBAH-BioPharm); Pharmacia-Upjohn, and MDS Pharma Services. Dr. Faragasso comes to Premier Research from Adolor Corporation where he established and managed a successful and growing safety department over the last 7 years.

"We are very pleased to have Dr. Faragasso join our Medical Affairs Department in this important role," said Dr. Kaba, Vice President, Global Medical Affairs and Strategic Product Development. "His expertise and proven leadership will strengthen our team and help us expand our medical and safety services to meet the evolving needs of our clients."

About Premier Research

Premier Research is a leading solutions-driven CRO leveraging their commitment to therapeutic focus and scientific expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research. Premier Research has 29 offices and operates in more than 30 countries across Europe and North America. They employ a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at a well-established network of dedicated clinical sites.

http://www.premier-research.com


'/>"/>
SOURCE Premier Research Group plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
2. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
3. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
4. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
5. Premier Research Appoints Global Head of Human Resources
6. Premier Research Appoints Melissa Jones as Vice President, International Business Development
7. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
8. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
9. Cato Research and Neuland Laboratories Form Cato Research Neuland India, Ltd.
10. AMTs Cooperative Research and Development Agreement With NIH to Boost Production Capacity
11. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Diego, CA (PRWEB) , ... ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically ... all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
Breaking Biology Technology:
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):